BDBM324254 US10189819, Example 108
SMILES: Cc1ccc(F)c2nc([nH]c(=O)c12)[C@@H](CNC(=O)c1ccc(cc1Cl)-c1ccc(=O)n(C)c1)c1cccc(F)c1
InChI Key:
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coagulation factor IX (Homo sapiens (Human)) | BDBM324254 (US10189819, Example 108) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme, Corp.; Mochida Paraceuticals Co., Ltd. US Patent | Assay Description Formation of a clot to stem bleeding at a site of blood vessel injury involves the coordinated activity of a group of plasma proteins that initiate a... | US Patent US10189819 (2019) BindingDB Entry DOI: 10.7270/Q200046Z | |||||||||||
More data for this Ligand-Target Pair |